Analyst Ratings for Medpace (MEDP)
MEDP Rating Summary
MEDP Price Target Summary
- Highest: $692.00 (RBC Capital)
- Lowest: $450.00 (Barclays)
- Average: $558.27
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$558.27 (-4.3%)
* Over Last 12-Mos
Rating Score: 2 / 10
Percentile Rank: 15%
Rating Score: 2 / 10
Percentile Rank: 15%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/8/2026 | Baird » Updated 7/24/2026 |
Eric Coldwell | Downgrade | Neutral (Outperform) |
624.00 (547.00) |
565.09 (583.21) |
3.21% | Details |
| 7/7/2026 | Jefferies | David Windley | Downgrade | Hold (Buy) |
515.00 (490.00) |
557.60 (583.21) |
4.59% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
